Trial Profile

Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 04 Nov 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Denosumab (Primary) ; Teriparatide
Indications Osteoporosis
Focus Therapeutic Use

Most Recent Events

19 Oct 2020 Planned End Date changed from 1 Aug 2020 to 1 Nov 2022.
10 Aug 2020 Planned End Date changed from 1 Dec 2019 to 1 Aug 2020.
19 May 2015 Planned primary completion date changed from 1 Sep 2014 to 1 May 2015, as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com